Dr Ravi Kiron has been appointed to advise OBJ Ltd’s business and licensing developments in North America. Dr Kiron is a former executive director of ALZA Corporation, a division of US pharmaceutical company Johnson & Johnson.
Subscribe today for award-winning, unbiased and trusted journalism